Aligos Therapeutics, Inc.ALGSNASDAQ

Revenue (LTM)

$2M

-44.6% YoY

Net Income (LTM)

$-24M

+81.6% YoY

Free Cash Flow

$-83M

Revenue CAGR (5Y)

—

Marginsdeclining

FCF($0.1B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	4	14↑219.0%	16↑11.7%	4↓74.6%	2↓44.6%
Gross Profit	4	14↑219.0%	16↑11.7%	4↓74.6%	1↓68.2%
Operating Income	-128	-98↑24.0%	-88↑9.7%	-89↓1.2%	-88↑1.3%
Net Income	-128	-96↑25.2%	-88↑8.7%	-131↓49.6%	-24↑81.6%
EBITDA	-125	-94↑24.6%	-85↑9.4%	-87↓1.7%	-87↓0.6%
EPS Diluted	-3.22	-2.25↑30.1%	-3.52↓56.4%	-20.94↓494.9%	-2.45↑88.3%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	187	81↓56.5%	136↑66.8%	37↓72.7%	18↓50.5%
Total Current Assets	204	134↓34.7%	141↑5.6%	62↓56.0%	83↑33.3%
Total Assets	235	147↓37.7%	152↑3.3%	70↓53.7%	89↑26.3%
Total Current Liabilities	39	33↓15.0%	24↓27.8%	22↓9.1%	21↓2.3%
Total Liabilities	51	43↓15.5%	59↑38.9%	99↑66.6%	35↓64.7%
Total Equity	185	104↓43.8%	92↓11.4%	-29↓131.5%	54↑284.8%
Total Debt	14	13↓13.0%	11↓11.4%	8↓24.8%	5↓37.3%
Net Debt	-172	-69↑60.1%	-125↓81.1%	-29↑77.0%	-13↑54.4%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-116	-79↑31.4%	-79↑0.5%	-81↓2.2%	-83↓2.2%
Capital Expenditure	-1	-1↓5.7%	-0↑98.0%	-0↓584.2%	-0↓236.2%
Free Cash Flow	-117	-80↑31.1%	-79↑1.6%	-81↓2.4%	-83↓2.6%
Stock-Based Comp	13	15↑9.2%	13↓13.9%	8↓33.2%	5↓40.3%
Net Change in Cash	-34	-106↓210.7%	54↑151.5%	-99↓281.7%	-19↑81.1%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance